Comparing Semaglutide vs Topiramate
Semaglutide | Topiramate |
|
---|
Semaglutide | Topiramate |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Prescription only
Topiramate may be prescribed either alone or in combination with other medications for the treatment of certain types of epilepsy, or it may be given for the prevention of migraines. Drowsiness is a... View more |
Related suggestions Weight Loss (Obesity/Overweight)
Popular comparisons
|
|||||||
More about Semaglutide | More about Topiramate | ||||||||
Ratings & Reviews | |||||||||
Semaglutide has an average rating of 6.9 out of 10 from a total of 2612 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
Topiramate has an average rating of 6.3 out of 10 from a total of 1332 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 28% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Semaglutide side effects |
View all Topiramate side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Topiramate prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Ozempic, Rybelsus, Wegovy | Eprontia, Qudexy XR, Topamax, Trokendi XR | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
168 hours |
56 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 273 drugs are known to interact with Semaglutide:
|
A total of 291 drugs are known to interact with Topiramate:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
December 05, 2017 |
December 24, 1996 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Repatha
Repatha (evolocumab) is a PCSK9 inhibitor used to lower high cholesterol alongside dietary changes ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Farxiga
Farxiga (dapagliflozin) is an oral prescription medication that may be given to certain adults with ...
Lasix
Lasix is a loop diuretic used to treat fluid retention from heart, liver, or kidney conditions, and ...
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.